Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.64 |
| ▸ | PTPN1 | P18031 | 8/20 | 0.49 |
| ▸ | HSP90AA1 | P07900 | 4/20 | 0.40 |
| ▸ | STAT3 | P40763 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Aucubin SCHEMBL381032 | 0.78 | L3MBTL1 (1.00) | L3MBTL1PTPN1HSP90AA1 | |
| Aucubin SCHEMBL22680274 | 0.78 | L3MBTL1 (1.00) | L3MBTL1PTPN1HSP90AA1 | |
| Aucubin SCHEMBL22680275 | 0.78 | L3MBTL1 (1.00) | L3MBTL1PTPN1HSP90AA1 | |
| SCHEMBL29544442 | 0.77 | L3MBTL1 (0.55) | L3MBTL1PTPN1HSP90AA1STAT3MAPT | |
| Geniposide SCHEMBL28006822 | 0.73 | PTPN1 (0.70) | PTPN1STAT3MAPT | |
| Geniposide SCHEMBL21765150 | 0.73 | PTPN1 (0.70) | PTPN1STAT3MAPT | |
| SCHEMBL29425905 | 0.71 | L3MBTL1 (0.48) | L3MBTL1PTPN1HSP90AA1STAT3MAPT | |
| SCHEMBL30558037 | 0.71 | L3MBTL1 (0.75) | L3MBTL1HSP90AA1MAPT | |
| SCHEMBL30904657 | 0.71 | PTPN1 (0.64) | PTPN1STAT3MAPT | |
| Trehalose SCHEMBL25304700 | 0.70 | MEN1 (0.57) | L3MBTL1PTPN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104782367-A | Artificial cultivation method for savatier monochasma herb | WANBANGDE HUNAN NATURAL PHARMACEUTICAL CO LTD | 2015-07-22 | — | — | CN | disclosed |
| US-20150150770-A1 | METHODS OF TREATING SKIN | TRACIE MARTYN INTERNATIONAL INC (US) | 2015-06-04 | — | — | US | disclosed |
| US-20140155961-A1 | METHODS OF TREATING SKIN | Tracie Martyn International, Inc. (US) | 2014-06-05 | — | — | US | disclosed |
| WO-2013172640-A1 | COMPOSITION HAVING HEAT SHOCK PROTEIN INDUCTION ACTIVITY AND COMPRISING COMPOUND ISOLATED FROM EUCOMMIA ULMOIDES | 이화여자대학교 산학협력단 (KR) | 2013-11-21 | — | — | WO | disclosed |
| CN-103197008-A | Method for controlling quality of Yanning granules | HUIZHOU JIUHUI PHARMACEUTICAL CO LTD | 2013-07-10 | — | — | CN | disclosed |
| US-20100272790-A1 | Methods of Treating Skin | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-10-28 | — | — | US | disclosed |
| CN-101129391-B | Medicament for eliminating OH free radical | CHINESE MEDICINE AND ETHNIC DRUG INST XINJIANG UYGUR AUTONOMOUS REGION | 2010-09-29 | — | — | CN | disclosed |
| US-7776915-B2 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2010-08-17 | — | — | US | disclosed |
| CN-101129391-A | Medicament for eliminating OH free radical | XINJIANG UYGUR AUTONOMOUS REGI (CN) | 2008-02-27 | — | — | CN | disclosed |
| US-20060216251-A1 | Topical formulations and methods of use | TRACIE MARTYN INTERNATIONAL, LLC (US) | 2006-09-28 | — | — | US | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140155961-A1 | METHODS OF TREATING SKIN | CUTA, LIPA, DLAT | L3MBTL1 574/4885PTPN1 4651/4885HSP90AA1 1810/4885 |
| US-20100272790-A1 | Methods of Treating Skin | CUTA, LIPA, DLAT | L3MBTL1 574/4885PTPN1 4651/4885HSP90AA1 1810/4885 |
| US-20150150770-A1 | METHODS OF TREATING SKIN | CUTA, LIPA, DLAT | L3MBTL1 574/4885PTPN1 4651/4885HSP90AA1 1810/4885 |
| US-20060216251-A1 | Topical formulations and methods of use | CPT1B, SLC25A20, CPT1A | L3MBTL1 847/4885PTPN1 3980/4885HSP90AA1 1768/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.